Continue to site >
Trending ETFs

Pacer BioThreat Strategy ETF

ETF
VIRS
Payout Change
Pending
Price as of:
$36.2627 +0.21 +0.59%
primary theme
U.S. Large-Cap Blend Equity
VIRS (ETF)

Pacer BioThreat Strategy ETF

Payout Change
Pending
Price as of:
$36.2627 +0.21 +0.59%
primary theme
U.S. Large-Cap Blend Equity
VIRS (ETF)

Pacer BioThreat Strategy ETF

Payout Change
Pending
Price as of:
$36.2627 +0.21 +0.59%
primary theme
U.S. Large-Cap Blend Equity

Name

As of 03/27/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$36.26

$3.53 M

0.88%

$0.32

0.70%

Vitals

YTD Return

12.5%

1 yr return

29.3%

3 Yr Avg Return

8.8%

5 Yr Avg Return

N/A

Net Assets

$3.53 M

Holdings in Top 10

69.5%

52 WEEK LOW AND HIGH

$36.1
$27.78
$36.26

Expenses

OPERATING FEES

Expense Ratio 0.70%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 5.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

N/A

IRA

N/A


Fund Classification

Fund Type

Exchange Traded Fund


Name

As of 03/27/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$36.26

$3.53 M

0.88%

$0.32

0.70%

VIRS - Profile

Distributions

  • YTD Total Return 12.5%
  • 3 Yr Annualized Total Return 8.8%
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio 0.65%
DIVIDENDS
  • Dividend Yield 0.9%
  • Dividend Distribution Frequency Quarterly

Fund Details

  • Legal Name
    Pacer BioThreat Strategy ETF
  • Fund Family Name
    Pacer
  • Inception Date
    Jun 24, 2020
  • Shares Outstanding
    200000
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Bruce Kavanaugh

Fund Description

The Fund employs a “passive management” (or indexing) investment approach designed to track the total return performance, before fees and expenses, of the Index. The Index is based on a proprietary methodology developed by LifeSci Index Partners, LLC, the Fund’s Index Provider (the “Index Provider”), which is not affiliated with the Fund, its distributor, or Pacer Advisors, Inc., the Fund’s investment adviser (the “Adviser”).
The Index
The Index is generally composed of U.S.-listed stocks of companies whose products or services help protect against, endure, or recover from biological threats to human health. Companies helping to protect against such threats include those that conduct research to identify or anticipate such threats and those developing or producing the tools necessary to detect them. Companies helping to endure biological threats include those offering goods or services to help individuals, organizations, businesses, and governments adapt to requirements for social distancing or remote connectivity. Such companies may reflect a variety of industries, ranging from the provision of consumer staples that may be stockpiled in an emergency to critical healthcare supplies to basic energy resources. Companies helping to recover from a biological threat include those that support the treatment of diseases or responses to chemical or biological attacks. The Index selects companies based on a proprietary, multi-step research process. First, the Index Provider conducts fundamental research to identify the most important current and emerging biological threats to human health. Such threats may include pandemic diseases, biological warfare, food and water safety, environmental safety, and natural disasters.
Next, the Index Provider utilizes publicly available information such as financial reports and screens, corporate websites, news reports, and interviews with key opinion leaders to identify publicly traded companies which protect against and prepare for recovering from these threats. These companies have products, technologies, and services that seek to:
research or combat pandemic diseases such as the novel coronavirus (COVID-19), Zika, H1N1, Ebola, avian flu, and MERS;
combat agents of biological or chemical warfare such as anthrax, sarin gas, variola virus, and brucellosis;
detect the presence of biological or chemical threats;
enable social distancing and increased productivity for working and shopping at home;
secure national borders and ports and strengthen homeland security;
aid in stockpiling of products in times of natural disasters and disease outbreaks, such as canned foods, power sources, consumer first aid kits, anti-microbial agents, gas masks, and sterilization supplies and services; and
test and improve food and water safety and purity.
Finally, the Index Provider only includes those companies with a minimum market capitalization of $1 billion and a minimum average daily value traded for the last six months of at least $2 million. Index components are weighted based on their market capitalization, subject to a maximum weight of 4.9% at the time of rebalance. The Index is reconstituted (i.e., components are added or removed and weights are reset based on the Index methodology) on the third Friday of each January and rebalanced (i.e., weights are reset based on the Index methodology, but no components are added or removed) semi-annually as of the close of business on the third Friday of each January and July. The weights are fixed as of closing prices on the second Friday in each January and July. As of June 30, 2023, the Index was made up of 50 companies and included significant allocations to companies in the health care and pharmaceutical sectors.
The Fund’s Investment Strategy
The Fund attempts to invest all, or substantially all, of its assets in the component securities that make up the Index. The Adviser expects that, over time, the correlation between the Fund’s performance and that of the Index, before fees and expenses, will be 95% or better.
The Fund will generally use a “replication” strategy to achieve its investment objective, meaning it will invest in all of the component securities of the Index in the same approximate proportion as in the Index. However, the Fund may use a “representative sampling” strategy, meaning it may invest in a sample of the securities in the Index whose risk, return and other characteristics closely resemble the risk, return and other characteristics of the Index as a whole, when the Adviser believes it is in the best interests of the Fund (e.g., when replicating the Index involves practical difficulties or substantial costs, an Index constituent becomes temporarily illiquid, unavailable, or less liquid, or as a result of legal restrictions or limitations that apply to the Fund but not to the Index).
The Fund generally may invest up to 20% of its total assets (exclusive of any collateral held from securities lending) in securities or other investments not included in the Index, but which the Adviser believes will help the Fund track the Index. For example, the Fund may invest in securities that are not components of the Index to reflect various corporate actions and other changes to the Index (such as reconstitutions, additions, and deletions).
The Fund is non-diversified and therefore may invest a larger percentage of its assets in the securities of a single company than diversified funds. 
To the extent the Index concentrates (i.e., holds more than 25% of its total assets) in the securities of a particular industry or group of related industries, the Fund will concentrate its investments to approximately the same extent as the Index. As of June 30, 2023, the Index was not concentrated in any industry or group of industries.
Read More

VIRS - Performance

Return Ranking - Trailing

Period VIRS Return Category Return Low Category Return High Rank in Category (%)
YTD 12.5% 0.3% 17.0% 4.85%
1 Yr 29.3% 3.7% 53.6% 66.59%
3 Yr 8.8%* -10.3% 30.6% 67.61%
5 Yr N/A* -7.9% 109.2% 72.40%
10 Yr N/A* 0.4% 21.0% 75.14%

* Annualized

Return Ranking - Calendar

Period VIRS Return Category Return Low Category Return High Rank in Category (%)
2023 14.5% -42.6% 47.4% 70.64%
2022 -18.9% -56.3% -4.2% 23.30%
2021 24.6% -27.2% 53.7% 16.80%
2020 N/A -36.2% 2181.7% N/A
2019 N/A -22.7% 40.4% N/A

Total Return Ranking - Trailing

Period VIRS Return Category Return Low Category Return High Rank in Category (%)
YTD 12.5% 0.3% 17.0% 4.85%
1 Yr 29.3% 3.7% 53.6% 66.59%
3 Yr 8.8%* -10.3% 30.6% 67.61%
5 Yr N/A* -7.9% 109.2% N/A
10 Yr N/A* 0.4% 21.0% N/A

* Annualized

Total Return Ranking - Calendar

Period VIRS Return Category Return Low Category Return High Rank in Category (%)
2023 15.7% -5.0% 47.4% 86.40%
2022 -18.0% -36.8% -2.2% 47.09%
2021 25.5% 3.0% 124.3% 62.66%
2020 N/A -15.8% 2266.0% N/A
2019 N/A -0.4% 241.3% N/A

VIRS - Holdings

Concentration Analysis

VIRS Category Low Category High VIRS % Rank
Net Assets 3.53 M 2.59 M 1.55 T 99.69%
Number of Holdings 54 1 4053 76.39%
Net Assets in Top 10 2.48 M 885 K 387 B 98.98%
Weighting of Top 10 69.55% 0.3% 112.0% 2.90%

Top 10 Holdings

  1. Mount Vernon Liquid Assets Portfolio, LLC 23.62%
  2. Amazon.com Inc 5.62%
  3. Walmart Inc 5.56%
  4. NVIDIA Corp 5.49%
  5. Netflix Inc 5.11%
  6. Home Depot Inc/The 4.99%
  7. Abbott Laboratories 4.85%
  8. Merck Co Inc 4.84%
  9. Johnson Johnson 4.83%
  10. Lowe's Cos Inc 4.64%

Asset Allocation

Weighting Return Low Return High VIRS % Rank
Stocks
99.83% 0.00% 124.03% 9.54%
Cash
23.72% 0.00% 99.06% 0.70%
Preferred Stocks
0.00% 0.00% 2.38% 38.23%
Other
0.00% -13.91% 100.00% 54.26%
Convertible Bonds
0.00% 0.00% 5.54% 34.98%
Bonds
0.00% -0.50% 94.15% 39.41%

Stock Sector Breakdown

Weighting Return Low Return High VIRS % Rank
Healthcare
60.70% 0.00% 60.70% 0.08%
Consumer Cyclical
12.75% 0.00% 30.33% 13.05%
Consumer Defense
11.34% 0.00% 47.71% 7.16%
Technology
7.18% 0.00% 48.94% 96.42%
Industrials
4.34% 0.00% 29.90% 98.01%
Communication Services
1.90% 0.00% 27.94% 94.51%
Basic Materials
1.80% 0.00% 25.70% 80.67%
Utilities
0.00% 0.00% 20.91% 90.53%
Real Estate
0.00% 0.00% 31.91% 91.09%
Financial Services
0.00% 0.00% 55.59% 99.76%
Energy
0.00% 0.00% 41.64% 90.77%

Stock Geographic Breakdown

Weighting Return Low Return High VIRS % Rank
US
99.83% 0.00% 124.03% 8.21%
Non US
0.00% 0.00% 62.81% 50.12%

VIRS - Expenses

Operational Fees

VIRS Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.70% 0.01% 16.07% 59.01%
Management Fee 0.70% 0.00% 1.89% 80.44%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.00% 0.85% N/A

Sales Fees

VIRS Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 1.00% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

VIRS Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 0.25% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

VIRS Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 5.00% 0.00% 496.00% 12.24%

VIRS - Distributions

Dividend Yield Analysis

VIRS Category Low Category High VIRS % Rank
Dividend Yield 0.88% 0.00% 25.10% 59.64%

Dividend Distribution Analysis

VIRS Category Low Category High Category Mod
Dividend Distribution Frequency Quarterly Annual Quarterly Semi-Annually

Net Income Ratio Analysis

VIRS Category Low Category High VIRS % Rank
Net Income Ratio 0.65% -54.00% 6.06% 52.19%

Capital Gain Distribution Analysis

VIRS Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Quarterly Annually

Distributions History

View More +

VIRS - Fund Manager Analysis

Managers

Bruce Kavanaugh


Start Date

Tenure

Tenure Rank

Jun 24, 2020

1.93

1.9%

Mr. Kavanaugh has been Vice President of the Adviser since it began operations in 2004. He has been a portfolio manager with the Adviser since 2013.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.04 39.02 7.21 2.42